- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03280953
Assessing Fluid Responsiveness With PWTT
Finding the Cut-off Value of Pulse Wave Transit Time (PWTT) to Estimate the Fluid Responsibility
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PWTT is determined by measuring the beginning and the end of pulse wave duration and can be calculated as the time interval from the ECG R-wave peak to the rise point of the pulse oximeter wave.
it consists of two components: pre ejection period (PEP) and arterial pulse wave transit time (a-PWTT). PEP is defined as the time from the ECG R wave to the rise point of the aortic root pressure wave. a-PWTT is defined as the time from the rise point of the aortic pressure wave to the rise point of the pulse oximeter wave. a-PWTT is the component which is directly related to the velocity of the pulse wave. However noninvasively, we can measure only PWTT, which also includes PEP. In general, PEP change over short periods of time is negligible in most cases, so we can assume that PWTT corresponds to
a-PWTT. In studies using several studies using animals and healthy volunteers, PWTT showed good correlation with stroke volume or systolic blood pressure. Also in experimental and clinical setting, it is shown that PEP changes indicate change in preloads.
It is not known at this moment, which of the following factors to be considered in processing raw data to acquire accurate PWTT value on predicting fluid responsiveness.
- The beginning of pulse wave can be assessed by the appearance of either Q wave, which represents the initial phase of depolarisation going through the interventricular septum or R wave, which represents the ventricular depolarisation in ECG.
- The end of pulse wave duration can be assessed by peripheral plethysmography mostly from a finger tip but also from an ear lobe.
- The pulse wave time can be simply measured as it is, but can also be adjusted by heart rate using Bazett-Formula.
- Not only the simple PWTT but also ventilatory induced fluctuation of PWTT (ΔPWTT) may be used for predicting fluid responsiveness.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Rheinland-Pfalz
-
Mainz, Rheinland-Pfalz, Germany, 55131
- University Medical Center of Johannes Gutenberg University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults 18 - 80 years old
- elective open abdominal surgery
- clinical indication for direct arterial blood pressure Monitoring
- supine Position intraoperatively
Exclusion Criteria:
- under 18 years, over 80 years old
- pregnant
- no informed consent
- systemic inflammatory response syndrome (SIRS) or Sepsis
- Severe cardiac, coronary or vascular disease
- Arrythmia
- Cardiac valves anomaly
- BMI > 35
- American Society of Anesthesiologists (ASA) physical status classification system: 4
- Lung disease that excludes Ventilation with a tidal volume >8ml/kg
- esophageal pathology
- planned prone position surgery
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PWTT change before and after fluid bolus
Time Frame: 1 day
|
PWTT recorded before and 1 minute after fluid bolus of 7ml/kg intraoperatively.
PWTT values will be calculated: defining PWTT start by either Q-wave or R-wave, defining PWTT end at arrival of the plethysmographic signal either at the finger tip or at the ear lobe, defining PWTT length by either simple measurement or adjusted by the Bazett-Formula.
Additionally, as a dynamic parameter respiratory variation of PWTT (ΔPWTT) will be computed.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heart rate before and after fluid bolus
Time Frame: 1 day
|
Heart rate (in beats per minute), derived from intraoperative standard monitoring.
This hemodynamic parameter will be measured before and 1min after fluid bolus.
|
1 day
|
Blood pressure before and after fluid bolus
Time Frame: 1 day
|
Systolic blood pressure/diastolic blood pressure/mean arterial pressure (in millimeters of mercury), derived from intraoperative standard monitoring.
This hemodynamic parameter will be measured before and 1min after fluid bolus.
|
1 day
|
Flow Time corrected before and after fluid bolus
Time Frame: 1 day
|
Flow Time corrected (in milliseconds) measured by esophageal doppler.
This hemodynamic parameter will be measured before and 1min after fluid bolus.
|
1 day
|
Stroke volume before and after fluid bolus
Time Frame: 1 day
|
Stroke volume (in milliliters per heartbeat) measured by esophageal doppler.
This hemodynamic parameter will be measured before and 1min after fluid bolus.
|
1 day
|
Pulse Pressure Variation before and after fluid bolus
Time Frame: 1 day
|
Pulse Pressure Variation (as percentage) assessed using arterial pressure monitoring.
This hemodynamic parameter will be measured before and 1min after fluid bolus.
|
1 day
|
Collaborators and Investigators
Investigators
- Principal Investigator: Kimiko Fukui-Dunkel, M.D., Ph.D., University Medical Center of Johannes Gutenberg University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 837.004.16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fluid Therapy
-
Nordsjaellands HospitalRigshospitalet, Denmark; University of CopenhagenRecruitingFluid Therapy | Fluid OverloadDenmark
-
Centre Hospitalier Universitaire, AmiensRecruitingFluid Therapy | Pharmacodynamics | Fluid Responsiveness | Fluid Challenge | Intravenous FluidsFrance
-
Uppsala UniversityCompletedFluid Therapy | Fluid Overload | Critical CareSweden
-
Erasme University HospitalUnknownFluid Therapy | Fluid and Electrolyte ImbalanceBelgium
-
Assiut UniversityCompleted
-
Rajiv Gandhi Cancer Institute & Research Center...Completed
-
Sociedad Española de Anestesiología, Reanimación...Hospital Clinic of Barcelona; Hospital Universitario La Fe; Hospital Universitario... and other collaboratorsUnknown
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalWithdrawnHemodynamic Monitoring | Fluid Management | Goal-Directed Fluid TherapyTurkey
-
Beijing Anzhen HospitalNot yet recruitingFluid Therapy | Microcirculation
Clinical Trials on Assessing fluid responsiveness by PWTT value
-
Al-Azhar UniversityCompletedShock | Transthoracic Echocardiography | Electrical Cardiometry | Fluid ResuscitationEgypt
-
Yonsei UniversityUnknownSeptic Acute Kidney InjuryKorea, Republic of